These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15916424

  • 1. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
    Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker JR.
    J Med Chem; 2005 Jun 02; 48(11):3729-35. PubMed ID: 15916424
    [Abstract] [Full Text] [Related]

  • 2. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
    Majoros IJ, Thomas TP, Mehta CB, Baker JR.
    J Med Chem; 2005 Sep 22; 48(19):5892-9. PubMed ID: 16161993
    [Abstract] [Full Text] [Related]

  • 3. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
    Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR.
    Biomacromolecules; 2006 Feb 22; 7(2):572-9. PubMed ID: 16471932
    [Abstract] [Full Text] [Related]

  • 4. Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis.
    Shi X, Majoros IJ, Patri AK, Bi X, Islam MT, Desai A, Ganser TR, Baker JR.
    Analyst; 2006 Mar 22; 131(3):374-81. PubMed ID: 16496045
    [Abstract] [Full Text] [Related]

  • 5. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
    Myc A, Douce TB, Ahuja N, Kotlyar A, Kukowska-Latallo J, Thomas TP, Baker JR.
    Anticancer Drugs; 2008 Feb 22; 19(2):143-9. PubMed ID: 18176110
    [Abstract] [Full Text] [Related]

  • 6. HPLC analysis of PAMAM dendrimer based multifunctional devices.
    Islam MT, Majoros IJ, Baker JR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug 05; 822(1-2):21-6. PubMed ID: 15950555
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
    Yue Y, Eun JS, Lee MK, Seo SY.
    Arch Pharm Res; 2012 Feb 05; 35(2):343-9. PubMed ID: 22370789
    [Abstract] [Full Text] [Related]

  • 8. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
    Zhang Y, Thomas TP, Desai A, Zong H, Leroueil PR, Majoros IJ, Baker JR.
    Bioconjug Chem; 2010 Mar 17; 21(3):489-95. PubMed ID: 20128612
    [Abstract] [Full Text] [Related]

  • 9. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
    Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR.
    Cancer Res; 2005 Jun 15; 65(12):5317-24. PubMed ID: 15958579
    [Abstract] [Full Text] [Related]

  • 10. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
    Patri AK, Kukowska-Latallo JF, Baker JR.
    Adv Drug Deliv Rev; 2005 Dec 14; 57(15):2203-14. PubMed ID: 16290254
    [Abstract] [Full Text] [Related]

  • 11. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
    Wen S, Liu H, Cai H, Shen M, Shi X.
    Adv Healthc Mater; 2013 Sep 14; 2(9):1267-76. PubMed ID: 23447549
    [Abstract] [Full Text] [Related]

  • 12. Targeting cancer cells with biotin-dendrimer conjugates.
    Yang W, Cheng Y, Xu T, Wang X, Wen LP.
    Eur J Med Chem; 2009 Feb 14; 44(2):862-8. PubMed ID: 18550227
    [Abstract] [Full Text] [Related]

  • 13. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
    Zong H, Thomas TP, Lee KH, Desai AM, Li MH, Kotlyar A, Zhang Y, Leroueil PR, Gam JJ, Banaszak Holl MM, Baker JR.
    Biomacromolecules; 2012 Apr 09; 13(4):982-91. PubMed ID: 22360561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
    Zhang Y, Thomas TP, Lee KH, Li M, Zong H, Desai AM, Kotlyar A, Huang B, Holl MM, Baker JR.
    Bioorg Med Chem; 2011 Apr 15; 19(8):2557-64. PubMed ID: 21459000
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells.
    Shi X, Wang SH, Lee I, Shen M, Baker JR.
    Biopolymers; 2009 Nov 15; 91(11):936-42. PubMed ID: 19603491
    [Abstract] [Full Text] [Related]

  • 19. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic Acid-multiwalled carbon nanotube conjugate.
    Das M, Datir SR, Singh RP, Jain S.
    Mol Pharm; 2013 Jul 01; 10(7):2543-57. PubMed ID: 23683251
    [Abstract] [Full Text] [Related]

  • 20. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
    Thomas TP, Huang B, Choi SK, Silpe JE, Kotlyar A, Desai AM, Zong H, Gam J, Joice M, Baker JR.
    Mol Pharm; 2012 Sep 04; 9(9):2669-2676. PubMed ID: 22827500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.